恶性(转移性)颈动脉体瘤临床诊疗现状与进展
Clinical Diagnosis and Treatment of Malignant (Metastatic) Carotid Body Tumor
DOI: 10.12677/ACM.2022.126797, PDF,   
作者: 张正轩:青海大学研究生院,青海 西宁;朱吉海, 武建英:青海大学附属医院心脏血管外科,青海 西宁
关键词: 恶性颈动脉体瘤生物学行为GAPPMalignant Carotid Body Tumor Biological Behavior GAPP
摘要: 颈动脉体瘤(CBT)是一种少见的副神经节来源性肿瘤,有一定恶变率,恶性颈动脉体瘤(MCBT)的诊断依据是是否发生淋巴结或远处转移,以及肿瘤的生物学行为。目前诊断MCBT尚无统一、有效的标准,且MCBT也缺乏有效治疗手段。故本文就近年来MCBT的诊断、生物学行为预测及治疗策略作一综述。
Abstract: Carotid body tumor (CBT) is a rare paraganglion derived tumor with a certain malignant transfor-mation rate. The diagnosis of malignant carotid body tumor (MCBT) is based on whether lymph node or distant metastasis occurs and the biological behavior of the tumor. At present, there is no unified and effective standard for the diagnosis of MCBT, and MCBT also lacks effective treatment. Therefore, this paper reviews the diagnosis, biological behavior prediction and treatment strategies of MCBT in recent years.
文章引用:张正轩, 朱吉海, 武建英. 恶性(转移性)颈动脉体瘤临床诊疗现状与进展[J]. 临床医学进展, 2022, 12(6): 5512-5518. https://doi.org/10.12677/ACM.2022.126797

参考文献

[1] 郭红磊, 贾彦焘. 颈动脉体瘤临床诊疗研究进展[J]. 临床误诊误治, 2021, 34(3): 108-112.
[2] 张彦梅, 关巍, 冯喜英. 低氧对颈动脉体结构和功能的影响[J]. 临床肺科杂志, 2016, 21(9): 1696-1700.
[3] Knight Jr., T.T., Gon-zalez, J.A., Rary, J.M. and Rush, D.S. (2006) Current Concepts for the Surgical Management of Carotid Body Tumor. The American Journal of Surgery, 191, 104-110. [Google Scholar] [CrossRef] [PubMed]
[4] Persky, M. and Tran, T. (2018) Acquired Vascular Tumors of the Head and Neck. Otolaryngologic Clinics of North America, 51, 255-274. [Google Scholar] [CrossRef] [PubMed]
[5] Robertson, V., Poli, F., Hobson, B., Saratzis, A. and Ross Naylor, A. (2019) A Systematic Review and Meta-Analysis of the Presentation and Surgical Management of Patients with Carotid Body Tumours. European Journal of Vascular and Endovascular Surgery, 57, 477-486. [Google Scholar] [CrossRef] [PubMed]
[6] Chen, Y., Li, Y., Liu, J. and Yang, L. (2020) The Clinical Charac-teristics and Outcomes of Carotid Body Tumors in Chinese Patients: A STROBE-Compliant Observational Study. Medi-cine (Baltimore), 99, e18824. [Google Scholar] [CrossRef
[7] 顾光超, 刘志丽, 刘暴, 刘昌伟, 叶炜, 陈跃鑫, 倪冷, 曾嵘, 邵江, 宋小军, 郑月宏. 恶性颈动脉体瘤的外科治疗[J]. 中华普通外科杂志, 2020, 35(3): 183-186.
[8] 任金锐, 顾光超, 李方达, 郑月宏. 颈动脉外科的现状与问题[J]. 血管与腔内血管外科杂志, 2021, 7(5): 580-584. [Google Scholar] [CrossRef
[9] Hinojosa, C.A., Anaya-Ayala, J.E., Olivares-Cruz, S., Laparra-Escareno, H., Trolle-Silva, A. and Angeles-Angeles, A. (2018) Malignant Shamblin III Carotid Body Tu-mors Resected with Use of the Retrocarotid Dissection Technique in 2 Patients. Texas Heart Institute Journal, 45, 92-95. [Google Scholar] [CrossRef
[10] Madan, R., Joshi, N.P., Mohanti, B.K. and Rath, G.K. (2013) Sys-temic Metastasis in a Carotid Body Tumor: A Rare Presentation of a Rare Tumor. The South Asian Journal of Cancer, 2, 97. [Google Scholar] [CrossRef
[11] Nautiyal, A., Mukherjee, A., Mitra, D., Chatterjee, P. and Roy, A. (2018) Carotid Body Tumor Masquerading as Metastatic Cervical Lymph Node on Fluorodeoxyglucose Posi-tron-Emission Tomography-Computed Tomography. Indian Journal of Nuclear Medicine, 33, 259-260.
[12] Rubio Maicas, C., Dualde Beltrán, D., Ferrández Izquierdo, A. and Nersesyan, N. (2019) Malignant Carotid Paraganglioma: A Case Report. Radiologia, 61, 171-176. [Google Scholar] [CrossRef
[13] 望云, 刘士远. 颈动脉体瘤的临床及影像学研究进展[J]. 中华实用诊断与治疗杂志, 2020, 34(12): 1294-1296. [Google Scholar] [CrossRef
[14] 张立华, 杨宁, 冯逢, 卫才永, 路军良, 马永强. 颈动脉体瘤的比较影像学诊断[J]. 中国医学影像技术, 2008, 24(1): 51-53.
[15] 郑曰宏, 管珩, 刘昌伟, 李拥军, 刘暴, 叶炜, 张严. 44例颈动脉体瘤的外科治疗[J]. 肿瘤, 2002, 22(1): 64-66.
[16] Thompson, L.D. (2002) Pheo-chromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign from Malignant Neoplasms: A Clinico-pathologic and Immunophenotypic Study of 100 Cases. The American Journal of Surgical Pathology, 26, 551-566. [Google Scholar] [CrossRef] [PubMed]
[17] DeLellis, R.A., Lloyd, R.V., Heitz, P.U., et al. (2004) World Health Organization Classification of Tumours. In: Pathology and Genetics of Tumour of Endocrine Organs, IARC Press, Lyon, 147-156.
[18] 祝宇, 蒋文, 林登强. 嗜铬细胞瘤生物学行为预测的演变[J]. 现代泌尿生殖肿瘤杂志, 2018, 10(5): 257-260.
[19] Kimura, N., Takayanagi, R., Takizawa, N., Itagaki, E., Katabami, T., Kakoi, N., Rakugi, H., Ikeda, Y., Tanabe, A., Nigawara, T., Ito, S., Kimura, I. and Naruse, M. (2014) Pathological Grading for Pre-dicting Metastasis in Phaeochromocytoma and Paraganglioma. Endocrine-Related Cancer, 21, 405-414. [Google Scholar] [CrossRef
[20] Lloyd, R.V., Osamura, R.Y., Kloppel, G. and Rosai, J. (2017) WHO Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. 4th Edition, IARC, Lyon.
[21] 王凤明, 章文成, 张仑. 15例恶性颈动脉体瘤的诊断与治疗[J]. 中国肿瘤临床, 2007, 34(20): 1185-1187.
[22] 汪忠镐. 颈动脉体瘤的外科治疗69例分析[J]. 中华普通外科杂志, 2002, 17(1): 8-10.
[23] 郑月宏, 顾光超, 周家伟. 颈动脉体瘤的诊治现状及进展[J]. 中华普通外科杂志, 2020, 35(3): 177-178.
[24] 顾光超, 郑月宏. 颈动脉体瘤的影像学检查及外科治疗进展[J]. 血管与腔内血管外科杂志, 2020, 6(5): 439-441. [Google Scholar] [CrossRef
[25] Katagiri, K., Shiga, K., Ikeda, A., Saito, D., Oi-kawa, S.I., Tshuchida, K., Miyaguchi, J., Tamura, A., Nakasato, T., Ehara, S. and Ishida, K. (2019) Effective, Same-Day Preoperative Embolization and Surgical Resection of Carotid Body Tumors. Head & Neck, 41, 3159-3167. [Google Scholar] [CrossRef] [PubMed]
[26] Ikeda, A., Shiga, K., Katagiri, K., Saito, D., Miyaguchi, J., Oikawa, S.I., Tsuchida, K., Asakage, T., Ozawa, H., Nibu, K.I., Ohtsuki, N., Fujimoto, Y. and Kaneko, K.I. (2018) Multi-Institutional Survey of Carotid Body Tumors in Japan. Oncology Letters, 15, 5318-5324. [Google Scholar] [CrossRef] [PubMed]
[27] Abu-Ghanem, S., Yehuda, M., Carmel, N.N., Abergel, A. and Fliss, D.M. (2016) Impact of Preoperative Embolization on the Outcomes of Carotid Body Tumor Surgery: A Meta-Analysis and Review of the Literature. Head & Neck, 38, E2386-E2394. [Google Scholar] [CrossRef] [PubMed]
[28] Cobb, A.N., Barkat, A., Daungjaiboon, W., Halandras, P., Crisostomo, P., Kuo, P.C. and Aulivola, B. (2020) Carotid Body Tumor Resection: Just as Safe without Preoperative Embolization. Annals of Vascular Surgery, 64, 163-168. [Google Scholar] [CrossRef] [PubMed]
[29] 张双燕, 崔立春, 杜建飞, 田春琴, 贺选, 蒋冬梅. 低分割放疗治疗颈部血管瘤的疗效观察[J]. 现代肿瘤医学, 2019, 27(12): 2147-2149.
[30] Patel, S.R., Winchester, D.J. and Benjamin, R.S. (1995) A 15-Year Experience with Chemotherapy of Patients with Paraganglioma. Cancer, 76, 1476-1480. [Google Scholar] [CrossRef
[31] 刘继前, 李光宗, 尚宪荣, 曹建春, 金潇, 曹刚, 黄强, 王吉亭, 郑硕, 李鹏, 张凡帆, 安李云, 顾汉程. 颈动脉体瘤的中西医结合治疗[J]. 中国医药导报, 2011, 8(31): 123-125.
[32] 中华医学会内分泌学分会. 嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版) [J]. 中华内分泌代谢杂志, 2020, 36(9): 737-750.